April 27, 2024

PATIENTS CARE ABOUT CURES, NOT CONFLICT OF INTEREST

More than a third of doctors who sit on review boards overseeing the integrity of clinical trials do not bother to disclose a financial stake in the outcome, a study in the New England Journal of Medicine has shown. However this does not shock cancer patients. In the same journal another study found that 80% were “not worried at all” if a doctor profited from a tested drug. In fact, most patients said that they opposed bans on such relationships. The author of the study said that this was quite understandable since participants in clinical trials “are very vulnerable, have a serious problem and want someone to care for it.”